
Job objective :
Responsible for ensuring that operational systems and processes comply with local and international regulations, as well as internal company standards. The role involves managing and improving operational processes related to change control, deviation management, and continuous improvement within the donor center and/or plasma logistic center. This position ensures compliance with industry regulations and company policies while enhancing operational efficiency through effective system oversight and process optimization.
Environment :
Collaborates with operations, production, validation, and quality teams to ensure seamless execution of change control and deviation documentation.
Work is performed in an office environment with exposure to electrical office equipment. Frequently sits for 6-8 hours per day. Repetitive hand movement of both hands with the ability to make fast, simple, repeated movements of the fingers, hands, and wrists. Occasionally walks and stands. Occasionally bends and twists neck. Light to moderate lifting and carrying objects with a maximum lift of 25lbs. Able to communicate information and ideas so others will understand; with the ability to listen to and understand information and ideas presented through spoken and written words and sentences. Interacts with others, relates sensitive information to diverse groups. Must work with diverse groups to obtain consensus on issues.
Key responsibility :
Deviation and CAPA Management:
Change Control Management:
Process Improvements:
Documentation Standardization:
Collaboration and Training:
Key Process Indicators
Other duties as assigned.
Academic experience required
Professional experience required
Computing skills
Personal skills
Languages
Proficiency in English and Arabic (professional-level reading, writing, and communication required).

Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.